FEASIBILITY AND EFFICACY OF INDUCTION DOCETAXEL, CISPLATIN, AND 5-FLUOROURACIL CHEMOTHERAPY COMBINED WITH CISPLATIN CONCURRENT CHEMORADIOTHERAPY FOR NONMETASTATIC STAGE IV HEAD-AND-NECK SQUAMOUS CELL CARCINOMAS

Prestwich, Robin; Oeksuez, Didem; Dyker, Karen; Coyle, Catherine; Sen, Mehmet

doi:10.1016/j.ijrobp.2011.03.043

FEASIBILITY AND EFFICACY OF INDUCTION DOCETAXEL, CISPLATIN, AND 5-FLUOROURACIL CHEMOTHERAPY COMBINED WITH CISPLATIN CONCURRENT CHEMORADIOTHERAPY FOR NONMETASTATIC STAGE IV HEAD-AND-NECK SQUAMOUS CELL CARCINOMAS

Copy For Citation

Prestwich R. J., Oeksuez D., Dyker K., Coyle C., Sen M.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, vol.81, no.4, 2011 (SCI-Expanded)

Publication Type: Article / Article
Volume: 81 Issue: 4
Publication Date: 2011
Doi Number: 10.1016/j.ijrobp.2011.03.043
Journal Name: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Istanbul University Affiliated: Yes

Abstract

Purpose: To report the experience of treating selected fit patients with locally advanced head-and-neck squamous cell carcinoma with three cycles of induction TPF (docetaxel 75 mg/m(2), cisplatin 75 mg/m(2), 5-fluorouracil 750 mg/m(2), Days 2-5) followed by concurrent three-weekly bolus cisplatin 100 mg/m(2) chemoradiotherapy.